SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-17-062375
Filing Date
2017-10-16
Accepted
2017-10-16 16:31:30
Documents
33
Period of Report
2017-08-31

Document Format Files

Seq Description Document Type Size
1 10-Q a17-20670_110q.htm 10-Q 351115
2 EX-31.1 a17-20670_1ex31d1.htm EX-31.1 10858
3 EX-31.2 a17-20670_1ex31d2.htm EX-31.2 10797
4 EX-32.1 a17-20670_1ex32d1.htm EX-32.1 6321
5 EX-32.2 a17-20670_1ex32d2.htm EX-32.2 6296
  Complete submission text file 0001104659-17-062375.txt   1308585

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bzyr-20170831.xml EX-101.INS 164283
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bzyr-20170831.xsd EX-101.SCH 14787
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bzyr-20170831_cal.xml EX-101.CAL 15878
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bzyr-20170831_def.xml EX-101.DEF 32376
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT bzyr-20170831_lab.xml EX-101.LAB 135834
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bzyr-20170831_pre.xml EX-101.PRE 85334
Mailing Address
Business Address 12000 RICHMOND AVE HOUSTON TX 77082
BURZYNSKI RESEARCH INSTITUTE INC (Filer) CIK: 0000724445 (see all company filings)

IRS No.: 760136810 | State of Incorp.: DE | Fiscal Year End: 0228
Type: 10-Q | Act: 34 | File No.: 000-23425 | Film No.: 171138981
SIC: 2835 In Vitro & In Vivo Diagnostic Substances